the Supply of ITU, EOL and Antibiotics Supportive Medicines for Covid-19 preparedness in Winter 2022/ Spring 2023
key details
| Value | £189,619 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 30 Dec 2022 |
| Contract start | 5 Apr 2023 |
| Contract end | 4 Apr 2024 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-c2916dbf-e21d-4912-84e7-7aeb7c29b274 |
Awards (3)
This procurement was awarded to 3 suppliers. Values shown are per-award; the notice total is £189,619.
| Supplier | Value | Date | Status |
|---|---|---|---|
| B. Braun Medical Limited shared | £189,619 | 4 Apr 2023 | active |
| Bowmed Ibisqus Limited shared | £189,619 | 4 Apr 2023 | active |
| hameln pharma ltd shared | £189,619 | 4 Apr 2023 | active |
description
The Department of Health and Social Care has concluded a procurement exercise through its Agency, UK Health Security Agency for and on behalf of the Secretary of State for Health and Social Care acting as part of the Crown ('Authority').
The Authority sought to procure ten licensed products which were divided into Lots, to top up the stockpile holdings of its Intensive Therapy Unit (ITU), End of Life (EoL) and Antibiotics Supportive Medicines in preparation for further waves of Covid 19 for Winter 2022 / Spring 2023.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 4 May 2023 | Award (award) | · | 70860988-77de-4228-a3bb-dfb3ec75754d-642375 |
more from Department of Health and Social Care (DHSC)
- Hugh's Report-MH Impact of Life-threatening Child Illness on families 2026 · £216,540 · 26 Jun 2026
- D&B + API Interface · £542,011 · 25 Jun 2026
- NCMP IT System - Discovery Phase · £183,768 · 19 May 2026
- DHSC: CL Temporary Executive Support to the Permanent Secretary - JW · £17,702 · 19 May 2026
- DHSC: GO: 26/27 - WIST: DAC hosting on CSP · £168,000 · 2 Apr 2026
- RM1043.8-1-DEPARTMENT OF HEALTH AND SOCIAL CARE - Find Public Health Data · £1,251,360 · 2 Apr 2026
- DHSC:NHST: National GP Engagement on Health Data · £267,000 · 31 Mar 2026
- DHSC: CL FGO Contingent Labour SD Extension · £133,710 · 31 Mar 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.